Literature DB >> 19274413

[Bullous keratopathy: etiopathogenesis and treatment].

Eliana Domingues Gonçalves1, Mauro Campos, Fabiana Paris, José Alvaro Pereira Gomes, Charles Costa de Farias.   

Abstract

Bullous keratopathy is characterized by corneal stromal edema with epithelial or subepithelial bullae due to cell loss and endothelial decompensation. In more advanced cases, subepithelial fibrosis, formation of a posterior collagenous layer or retrocorneal fibrous membrane, and corneal vascularization can occur. Decreased vision is present because the loss of corneal transparency with symptoms like tearing and pain caused by epithelial bullae that can rupture. Currently, bullous keratopathy is the most common indication for penetrating keratoplasty and regraft. The main etiology is the endothelial cell loss after ophthalmic surgeries as cataract surgery. Cataract affects approximately 20 million people worldwide, and this complication can occur in 1 to 2% of cataract surgeries. This study revised bullous keratopathy etiopathogenesis, clinical and surgical treatment available for this corneal disease.

Entities:  

Mesh:

Year:  2008        PMID: 19274413     DOI: 10.1590/s0004-27492008000700012

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  4 in total

Review 1.  Diseases of the corneal endothelium.

Authors:  Lauren J Jeang; Curtis E Margo; Edgar M Espana
Journal:  Exp Eye Res       Date:  2021-02-14       Impact factor: 3.467

2.  The corticosteroids effect on corneal endothelial cell in pulse therapy, specific to the cataract surgery.

Authors:  A C Ghita; A M Ghita; M Noaghi; A Popa Cherecheanu
Journal:  J Med Life       Date:  2014

3.  Corneal Collagen Cross Linking (CXL) in treatment of Pseudophakic Bullous Keratopathy.

Authors:  Muhammad Saim Khan; Imran Basit; Mazhar Ishaq; Tariq Shakoor; Amer Yaqub; Rana Intisar
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

Review 4.  Pseudophakic bullous keratopathy.

Authors:  Stefan Pricopie; Sanziana Istrate; Liliana Voinea; Costin Leasu; Vanessa Paun; Ciuluvica Radu
Journal:  Rom J Ophthalmol       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.